Shanghai Medicine wading Medicine Electric dealer, net sells prescription medicine spring arrives?

[The net sale of prescription drugs as the future sales focus, does this move of Shanghai medicine mean that the net sale of prescription drugs to the lifting of the spring is coming?]

"At present, the prescription drug network is not open, we will use DTP (direct delivery of high-value drugs) for the incision, to carry out the relevant business." "March 10," Shanghai Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Shanghai Medicine") (601607.SH) Insider Feng in the "First financial daily," the reporter told the interview.

Before March 9 evening, Shanghai Medicine issued a notice said, will be with the natural person third place joint investment set up Shanghai Medical Health Co., Ltd., wading medicine, which Shanghai pharmaceutical investment of 70 million yuan, accounting for 70%, second runner-up 30 million yuan, accounting for 30% of the shares.

The announcement was issued the following day, Shanghai medicine shares in the high, and pull to limit trading.

It is understood that the second runner-up current position for the Shanghai Public Association Pharmaceutical Co., Ltd. General manager, and hold the company 21.56% of the equity. The pharmaceutical industry is a subsidiary of Shanghai Medicine, and it is the only high-end drug direct delivery business platform (DTP). Feng told reporters that after the establishment of the new company, the platform will become the primary weapon for business promotion.

In the announcement, Shanghai Medical disclosed that the establishment of the company's core is to create "electronic prescriptions", "drug data" and "patient data" three major platforms, to provide online solutions under the line. The new company's positioning will also provide patients with prescription drug O2O sales, health management services and trade-related electricity providers, the source said. This position coincides with the "Big Health strategy" announced by the Shanghai Medical Executive Director and President Zomin in the media briefing.

"In the future our business will still be cut with prescription drug O2O," he said. Compared to a number of integrated pharmaceutical companies to build pharmaceutical manufacturers, our advantage is that we have a lot of hospitals with the depth of cooperation, in the hospital prescription construction, docking his system has rich experience. Shanghai medicine is shown in the bulletin.

Does the Shanghai Medicine act as a way of selling prescription drugs to the market as the future sales focus?

In previous years, with Ali, Tencent, Beijing-east and other electric giants and including Shanghai Pharmaceutical, the Competition of medicine group, such as Chinese medicine Holding, Yi Tang, Cambe and so on, the domestic pharmaceutical electric Power company has formed a variety of modes: the day Cat Medicine Hall, the Beijing East Medicine city and so on constructs the third party platform, the Kyushu pass, the heart Church and so on the medicine circulation enterprise own platform In addition, such as Jian one network, such as vertical medical and electronic business.

Data show that last year, the size of domestic pharmaceutical manufacturers reached 4 billion yuan, and in 2010, the field is just starting to start, a short period of 3 growth rate of 250.35%. The capital competition can be seen.

A report in early 2014 shows that there are about 15,000 kinds of drugs in our country at present, OTC (over-the-counter drugs) is 4,727, in 2013, the market scale of OTC drugs is 178.3 billion yuan. This figure is huge, but compared to 1.3 trillion yuan in the whole medicine circulation market, it is only bucket. In this context, it is not surprising that medical and electronic providers are calling for a rise in the sound of over-the-counter prescription drugs.

In fact, since May 28 last year, the state Drug Administration issued the "Internet Food and drug management measures ﹙ soliciting comments draft ﹚" Since the ban on the sale of prescription drugs has been "hair-trigger" trend of the market and financial attention. The official notice of the administration, which contains the ban on the sale of prescription drugs, was once rumored to have been promulgated before and after the New Year's Day, but as of now, nine months later, formal notice has not yet been issued.

Prescription drug sales are difficult to open, in addition to drug safety, prescription outflow has become difficult to ban another "stumbling block."

At present, the major chain stores in the physical stores in the prescription drug sales mainly rely on the medical institutions of the prescription list, by the pharmacy licensed Pharmacists Review the list, and then sell prescription drugs. So, where do the prescription drugs from the online pharmacy come from?

A chain of drug owners said that the net sale of prescription drugs first involves prescription and prescription electronics. The electronic prescription is not difficult, the prescription is related to doctors and hospital motivation, because it means losing most of their income, the hospital is unwilling to give up their "prescription property."

It is noteworthy, however, that just before March 3, Guangzhou Food and Drug Administration official website announced a group of September 2014 to the end of January this year, the production operators list of illegal activities, including Guangzhou Love Kang Chain Pharmacy, Guangzhou Tianhe District Dong fraternity pharmacy Dragon stores are due to the use of different forms of the net sale prescription drugs and the list.

"Online pharmacies selling prescription drugs privately have become a public secret in the industry," he said. An insider from a pharmaceutical company told reporters. The huge profits of prescription drugs stimulate the internet pharmacies repeatedly broken, and the convenience of purchase and price advantage is full of temptation for patients.

Should be sparse not blocked, become a lot of people in the industry to open up the network to sell prescription drugs consistent attitude.

Prior to the news that the first batch of open Internet drugs catalogue mainly chronic diseases, these types of drugs for patients with long-term medication, drug risk is lower. But earlier media reports at a coordination meeting convened by the National Food and Drug Administration, it has been largely determined that the "online catalog" may no longer be developed, but that it is a list of drugs that cannot be marketed, and that the so-called "negative list", prescription drugs outside the negative list, can be sold on the Internet by prescription.